CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma Cells

Background/Aims: Metastasis is the major cause of death in patients with osteosarcoma. There is an urgent need to identify molecular markers that promote metastasis. Cluster of differentiation 44 is a receptor for hyaluronic acid (HA) and HA-binding has been proven to participate in various biologic...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Tang Liu, Zuyun Yan, Yong Liu, Edwin Choy, Francis J. Hornicek, Henry Mankin, Zhenfeng Duan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Cell Physiol Biochem Press GmbH & Co KG 2018-04-01
Saila:Cellular Physiology and Biochemistry
Gaiak:
Osteosarcoma
CRISPR-Cas9
Meta-analysis
CD44
Metastases
Gene therapy
Sarrera elektronikoa:https://www.karger.com/Article/FullText/489072
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak